Clinical trial

Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection

NCT07128888

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-17

PhasePHASE1

Conditions

Obesity or Overweightunresolved

Interventions

GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tabletsDRUG

Sponsors & collaborators

Gan & Lee Pharmaceuticals.lead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07128888 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.